US Bancorp
HUMA icon

US Bancorp’s Humacyte HUMA Stock Holding History

US Bancorp’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95K Hold
2,500
– – ﹤0.01% 3877
2026
Q1 		$1.52K Hold
2,500
– – ﹤0.01% 3862
2025
Q4 		$2.4K Hold
2,500
– – ﹤0.01% 3724
2025
Q3 		$4.35K Sell
2,500
-491
-16% -$962 ﹤0.01% 3580
2025
Q2 		$6.25K Buy
2,991
+491
+20% +$943 ﹤0.01% 3566
2025
Q1 		$4.26K Sell
2,500
-57
-2% -$214 ﹤0.01% 3703
2024
Q4 		$12.9K Buy
2,557
+57
+2% +$282 ﹤0.01% 3321
2024
Q3 		$13.6K Hold
2,500
– – ﹤0.01% 3250
2024
Q2 		$12K Hold
2,500
– – ﹤0.01% 3248
2024
Q1 		$7.78K Hold
2,500
– – ﹤0.01% 3414
2023
Q4 		$7.1K Hold
2,500
– – ﹤0.01% 3421
2023
Q3 		$7.33K Buy
+2,500
New +$8.27K ﹤0.01% 3288

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

US Bancorp's HUMA Position: Q2 2026 in Review

US Bancorp held its Humacyte (HUMA) position steady in Q2 2026 at 2,500 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #3877.

US Bancorp first reported a position in HUMA in Q3 2023 and has held it in 12 quarters since. The position peaked at $13.6K in Q3 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • US Bancorp held 2,500 shares of Humacyte worth $1.95K as of Q2 2026.
  • US Bancorp left its Humacyte share count unchanged in Q2 2026.
  • Humacyte made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3877 holding.
  • US Bancorp first reported a position in Humacyte in Q3 2023 and has held it in 12 quarters since.
  • US Bancorp's Humacyte position peaked at $13.6K in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.